FDA Drug Risk Evaluation Deputy Avigan Is Gastrointestinal Specialist

CDER Division of Drug Risk Evaluation Deputy Director Mark Avigan, MD, has expertise in gastrointestinal safety issues

More from Archive

More from Pink Sheet